Your healthcare provider should do blood tests to check how well your liver is working before you begin treatment with IXEMPRA and as needed during treatment. If blood tests show that you have liver problems, do not receive injections of IXEMPRA along with capecitabine. If you have liver problems, taking these medicines together could increase your chance of serious infection and death due to a very low white blood cell count (neutropenia).
You should not have your injection of IXEMPRA if you are allergic to medicines that contain Cremophor® EL* (polyoxyethylated castor oil) or if you have a low white blood cell count or a low platelet count. Continue to full Important Safety Information below
IXEMPRA a prescription medicine, used to treat breast cancer when certain medicines have not worked or no longer work can be used alone or with capecitabine.
Anthracycline (An-thruh-SY-clean) A type of medicine that damages the DNA in cancer cells, causing them to die
Chemotherapy A type of cancer treatment that uses certain medicines to destroy cancer cells. It can also harm healthy cells
Locally advanced Cancer that has spread from the breast to nearby tissue or lymph nodes
Lymph nodes Small masses of tissue that are an important part of the immune system. The lymph nodes act as filters that trap harmful things in the body
Metastatic (Meh-tuh-STA-tik) Cancer that has spread from the breast to other parts of the body
Preauthorization When the insurance company decides if a treatment is medically necessary for the patient and will be paid for by the insurance company
Taxane A type of medicine that stops cancer cells from dividing
Please see the complete Important Safety Information, including boxed WARNING regarding liver disease.
IXEMPRA is a prescription medicine used to treat locally advanced or metastatic breast cancer following certain treatments. IXEMPRA can be used alone or with another cancer medicine called Xeloda® (capecitabine).
IXEMPRA is a trademark of Bristol-Myers Squibb Company. *Cremophor is a registered trademark of BASF AG. Xeloda is a registered trademark of Roche Laboratories. © 2010 Bristol-Myers Squibb, Princeton, New Jersey 08543 U.S.A. All rights reserved.
691US09WA1490110/10
A type of cancer treatment that uses certain medicines to destroy cancer cells. It can also harm healthy cells
A type of medicine that damages the DNA in cancer cells, causing them to die
Cancer that has spread from the breast to nearby tissue or lymph nodes
Small masses of tissue that are an important part of the immune system. The lymph nodes act as filters that trap harmful things in the body
Cancer that has spread from the breast to other parts of the body
When the insurance company decides if a treatment is medically necessary for the patient and will be paid for by the insurance company
A type of medicine that stops cancer cells from dividing